PATENT CLAIM ANALYSIS

Application Number: 16301240
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-06
Patent Classification: ["514", "115000"]

Abstract:
The present invention relates to compounds for use in the prevention and/or treatment of PAR-related diseases, such as for example: pain and ocular disorders. More in particular, the present invention provides bis(acetamidophenyl) guanidinophenylethylphosphonates for use in the prevention and/or treatment of pancreatitis-related pain, IBS (irritable bowel syndrome), IBD (inflammatory bowel disease), dry eye disease and conjunctivitis sicca. These inhibitors were found to have a different inhibitory profile compared to diphenyl guanidinophenylethylphosphonates leading to a more pronounced effect on these conditions.

Claim (Index 27):
A method for preventing or treating at least one PAR-related disease selected from the group consisting of pain, ocular surface disease, tissue damage, skin disorders, respiratory disorders, and gastrointestinal disorders, the method comprising:\n administering to a subject in need thereof a therapeutically effective amount of a bis(acetamidophenyl) guanidinophenylethylphosphonate compound according to  claim 16 .

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13543022', '11722952', '13997979', '15309195', '12176279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.752694246043711
- 35 USC 102 Novelty (BERT): 0.4948822217443707
- Combined Prediction Score: 0.726913043613777
- Mean Citation Score: 213.648352
- Max Citation Score: 226.32257
- Similarity Product: 160.17342327816132

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test